Geneos Wealth Management Inc. Intercept Pharmaceuticals, Inc. Transaction History

Geneos Wealth Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Sep 07, 2021	SELL	$91.83 - $120.68 $18,366 - $24,136	-200 Reduced 33.33%	400 $44,000
Q4 2018 Sep 07, 2021	BUY	$85.79 - $126.46 $8,579 - $12,646	100 Added 20.0%	600 $56,000
Q3 2018 Sep 07, 2021	BUY	$88.49 - $127.55 $8,849 - $12,755	100 Added 25.0%	500 $63,000
Q3 2017 Sep 07, 2021	BUY	$57.01 - $118.75 $22,804 - $47,500	400	400 $23,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.